Clinical Report: HPV Vaccination Effects on CIN2+ Recurrence Following Conization

Overview

A systematic review and meta-analysis found that adjuvant HPV vaccination significantly reduces the risk of CIN2+ recurrence following conization, with a pooled relative risk of 0.38.

Background

Cervical intraepithelial neoplasia (CIN) is a precursor to cervical cancer, and its recurrence after treatment poses a significant clinical challenge. HPV vaccination has been proposed as an adjuvant therapy to reduce recurrence rates.

Data Highlights

Key Findings

• The pooled relative risk of CIN2+ recurrence with HPV vaccination is 0.38, indicating a 62% lower risk.
• Observational studies reported a more significant effect (RR 0.29) compared to randomized trials (RR 0.55).
• Re-analysis of randomized trials yielded a pooled RR of 0.56, suggesting a 44% reduction in recurrence.
• Healthy user bias may influence the perceived effectiveness of vaccination in observational studies.
• All four randomized trials showed a consistent direction of effect despite methodological limitations.

Clinical Implications

Clinicians should consider the potential for overestimation of HPV vaccination benefits based on study design when advising patients on post-conization treatment options.

Conclusion

The systematic review and meta-analysis support the beneficial role of HPV vaccination in reducing CIN2+ recurrence.

Related Resources & Content

1. Maiorano MFP et al., Frontiers in Oncology, 2026 -- Analysis of HPV Vaccination Effects on CIN2+ Recurrence Following Conization
2. MDSpire News — HPV Vaccine After Surgery Reduces Virus Persistence
3. the asco post — Cervical Precancer Incidence Decreases as HPV Vaccination Rates Rise
4. MDSpire News — Reduced Cervical Cancer Screening for HPV-Vaccinated Women
5. The ASCO Post — Early-Stage Cervical Cancer: Defining Follow-up After Fertility-Sparing Surgery
6. HPV Vaccine After Surgery Reduces Virus Persistence
7. Cervical Precancer Incidence Decreases as HPV Vaccination Rates Rise
8. Reduced Cervical Cancer Screening for HPV-Vaccinated Women
9. ASCCP Statement on HPV Vaccination
10. Frontiers | Impact of HPV vaccine on CIN2+ recurrence after conization: a systematic review and meta-analysis of vaccination timing, valency and surgical margins